Increased procoagulant phospholipid activity in blood from patients with suspected acute coronary syndromes: a pilot study.
Increased platelet activation is well documented in patients with acute coronary syndromes and can be detected by various methods, including flow cytometry and enzyme-linked immunosorbent assay. However, such techniques require several steps and cannot provide quick results. Platelet activation ultimately results in procoagulant phospholipid exposure and we have previously described a simple activated factor X-activated clotting time (XACT) test that is insensitive to resting platelets but that is significantly shortened by activated platelets, microparticles and procoagulant phospholipids. Our aim was to determine whether the XACT test could be used to distinguish patients with chest pain due to cardiac ischaemia from those having chest pain due to non-cardiac causes. We thus carried out XACT tests on ethylenediamine tetraacetic acid whole blood and plasma samples obtained from 46 patients presenting to the emergency department with chest pain and from 30 controls. Sixteen cases (30%) were subsequently diagnosed as acute coronary syndromes. Blood samples from these patients displayed overall significantly shortened XACT results relative to both healthy controls (P<0.001) and chest pain not due to cardiac ischaemia (P<0.004). This discrimination was much better with whole blood samples than when platelet-poor plasmas were tested (P=0.153), suggesting that free microparticles were not the only factors responsible. Thus, the detection of increased procoagulant phospholipid activity in whole blood by shortened XACT results may be a simple and rapid diagnostic marker of some cardiac ischaemic events.
Exner
Thomas
T
St Vincents Hospital, Darlinghurst, New South Wales, Australia. exner@optushome.com.au
Joseph
Joanne E
JE
Connor
David
D
Low
Joyce
J
Ma
David D F
DD
D000208:Acute Disease; D000368:Aged; D000787:Angina Pectoris / Q000097:blood / Q000175:diagnosis; D001779:Blood Coagulation Factors / Q000032:analysis*; D001780:Blood Coagulation Tests / Q000379:methods*; D002637:Chest Pain / Q000097:blood / Q000175:diagnosis; D003327:Coronary Disease / Q000097:blood* / Q000175:diagnosis; D005170:Factor X / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood*; D010865:Pilot Projects; D015539:Platelet Activation; D011237:Predictive Value of Tests; D013577:Syndrome; D013925:Thromboplastin / Q000378:metabolism; D013997:Time Factors
D001779:Blood Coagulation Factors; D010743:Phospholipids; D005170:Factor X; D013925:Thromboplastin